Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Scholoff, A."'
Autor:
Zhang, Yuqi 1, Gong, Zimu 1, Obi, Gloria 1, 2, Scholoff, Audrey 1, Cox, Jacob 1, Oki, Shalewa 1, Carrum, George 1, 2, Kamble, Rammurti 1, 2
Publikováno v:
In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S446-S447
Autor:
Gong, Zimu 1, Zhang, Yuqi 1, Obi, Gloria 1, 2, Scholoff, Audrey 1, Cox, James 1, Jacob, Susan 1, Oki, Shalewa 1, Carrum, George 2, 1, Kamble, Rammurti 2, 1
Publikováno v:
In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S439-S439
Autor:
Cynthia El Rahi, James Eldin Cox, Romelia May, George Carrum, Gloria Obi Anyadike, Audrey Scholoff, Rammurti Kamble
Publikováno v:
Clinical Medicine Insights: Blood Disorders, Vol 11 (2018)
Background: When used for hematopoietic stem cell mobilization, plerixafor was originally recommended to be administered 11 hours prior to apheresis based on the peak effect of 10 to 14 hours translating into an administration time of 10 to 11 pm . R
Externí odkaz:
https://doaj.org/article/97c33263eaf74bb9a98aa64e051a2bcc
Autor:
Yuqi Zhang, Zimu Gong, Gloria Obi, Audrey Scholoff, Jacob Cox, Shalewa Oki, George Carrum, Rammurti Kamble
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S446-S447
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80b2d85b34cf2bc3e5a12705b6946c3e
https://doi.org/10.1016/s2152-2650(22)01671-8
https://doi.org/10.1016/s2152-2650(22)01671-8
Autor:
Yuqi Zhang, Zimu Gong, Gloria Obi, Audrey Scholoff, Jacob Cox, Shalewa Oki, George Carrum, Rammurti Kamble
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S188
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4880fc2611b682f5cf84ac0e6348ef61
https://doi.org/10.1016/s2152-2650(22)01170-3
https://doi.org/10.1016/s2152-2650(22)01170-3
Autor:
Zimu Gong, Yuqi Zhang, Gloria Obi, Audrey Scholoff, James Cox, Susan Jacob, Shalewa Oki, George Carrum, Rammurti Kamble
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S439
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72a9ff259e191d87eb1ae4f8679f9c51
https://doi.org/10.1016/s2152-2650(22)01656-1
https://doi.org/10.1016/s2152-2650(22)01656-1
Autor:
George Carrum, Hussein Hamad, Rammurti T. Kamble, Helen E. Heslop, Sai Ravi Pingali, Albert Jang, Mahmoud Gaballa, Carlos A. Ramos, Gloria Obi, Premal Lulla, Shaun Bulsara, Meng-Fen Wu, LaQuisa Hill, Audrey Scholoff, Ngoc Vu
Publikováno v:
Journal of Clinical Oncology. 38:e19525-e19525
e19525 Background: Myeloablative conditioning (MAC) and unrelated donor (UD) hematopoietic cell transplantation (HCT) are associated with increased non-relapse mortality (NRM) compared with matched related donor (MRD) HCT [18%, 21%, and 32% for MRD,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca975e57c224de75898e4867fea377c8
https://doi.org/10.1200/jco.2020.38.15_suppl.e19525
https://doi.org/10.1200/jco.2020.38.15_suppl.e19525
Autor:
Gloria Obi Anyadike, Rammurti T. Kamble, George Carrum, James E. Cox, Romelia May, Cynthia El Rahi, Audrey Scholoff
Publikováno v:
Clinical Medicine Insights: Blood Disorders, Vol 11 (2018)
Clinical Medicine Insights: Blood Disorders
Clinical Medicine Insights: Blood Disorders
Background: When used for hematopoietic stem cell mobilization, plerixafor was originally recommended to be administered 11 hours prior to apheresis based on the peak effect of 10 to 14 hours translating into an administration time of 10 to 11 pm. Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c2a21c47c35fd89a428a0e0973842dc
https://doaj.org/article/97c33263eaf74bb9a98aa64e051a2bcc
https://doaj.org/article/97c33263eaf74bb9a98aa64e051a2bcc
Autor:
Rammurti T. Kamble, Ngoc Vu, Gloria Obi, Akash Mukherjee, Audrey Scholoff, Ekim Ekinci, George Carrum
Publikováno v:
Bone marrow transplantation. 54(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d6faa10791b53dcf387ec76b52bee1b
https://pubmed.ncbi.nlm.nih.gov/30087464
https://pubmed.ncbi.nlm.nih.gov/30087464
Autor:
Brennan M. Parmelee, Premal Lulla, Josie Sena, LaQuisa Hill, Gloria Obi Anyadike, George Carrum, Audrey Scholoff, Kimberly East, Carlos A. Ramos, Helen E. Heslop, Marsha Cohen, Jaya Paranilam
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S201
Introduction An adequate dose of marrow derived total nucleated cells (TNCs) is essential for engraftment in recipients undergoing allogeneic hematopoietic stem cell (HSC) transplant. Marrow collection centers anticipate the harvest volume required t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::572976638b61e013c1624c13de310608
https://doi.org/10.1016/j.bbmt.2018.12.336
https://doi.org/10.1016/j.bbmt.2018.12.336